Five-flavor Sophora flavescens Enteric-coated Capsules Alleviate Experimental Colitis and Ferroptosis-related Changes
Journal of Visualized Experiments · 2026
DOI: 10.3791/70711 ↗Kurz gefasst
Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2026. Verfasst von Zhaohan Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College. Hauptthemen laut MEDLINE: Ferroptosis, Colitis, Ulcerative, Sophora flavescens. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Ulcerative colitis remains difficult to manage because effective and targeted therapeutic options are limited, and oxidative stress, inflammatory signaling, and regulated cell-death pathways may contribute to mucosal injury. This study evaluated whether five-flavor Sophora flavescens enteric-coated capsules (FSEC) alleviate experimental colitis and explored associated changes in oxidative stress, inflammation, and markers of ferroptosis. A mouse model of ulcerative colitis was established using cyclic exposure to 2.5% dextran sulfate sodium, combined with tumor necrosis factor alpha challenge. Mice were treated with low-, medium-, or high-dose FSEC or with the TLR4 antagonist CRX-526 as a positive-control intervention. Colon histopathology was assessed by hematoxylin and eosin staining. Serum superoxide dismutase, catalase, glutathione, myeloperoxidase, and Fe2⁺ levels were measured using biochemical assays. Colon tissue cytokines were quantified by enzyme-linked immunosorbent assay, JAK2 and STAT3 expression were evaluated by immunohistochemistry, and GPX4, FTH1, and ACSL4 expression were analyzed by western blotting. FSEC treatment reduced colonic mucosal injury and inflammatory-cell infiltration, increased antioxidant indices, and decreased myeloperoxidase levels. FSEC also reduced TNF-α and IL-1α levels, partially restored IL-13 levels, and was associated with weaker JAK2 and STAT3 immunostaining. In parallel, FSEC improved ferroptosis-related marker changes, including reduced Fe2⁺ and ACSL4 levels and increased GPX4 and FTH1 expression. These findings suggest that FSEC alleviates experimental ulcerative colitis in mice, at least in part by improving oxidative-stress status, moderating inflammatory signaling, and restoring ferroptosis-related marker profiles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College.
- Department of Integrated Traditional Chinese and Western Medicine, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College.
- Department of Gastroenterology and Hepatology, Pengze County People's Hospital.
- Department of Gastroenterology and Hepatology, General Hospital of Pingxiang Mining Group Company.
- Department of Rehabilitation Medicine, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College; zsr102600@163.com.
Zitieren
APA
Wang, Z., Xiang, Y., Yu, T., Liu, K., Li, W., & Zhong, S. (2026). Five-flavor Sophora flavescens Enteric-coated Capsules Alleviate Experimental Colitis and Ferroptosis-related Changes. Journal of Visualized Experiments. https://doi.org/10.3791/70711
Vancouver
Wang Z, Xiang Y, Yu T, Liu K, Li W, Zhong S. Five-flavor Sophora flavescens Enteric-coated Capsules Alleviate Experimental Colitis and Ferroptosis-related Changes. Journal of Visualized Experiments. 2026. doi:10.3791/70711
BibTeX
@article{Wang2026,
author = {Wang, Zhaohan and Xiang, Yanru and Yu, Tao and Liu, Kun and Li, Wang and Zhong, Shirong},
title = {Five-flavor Sophora flavescens Enteric-coated Capsules Alleviate Experimental Colitis and Ferroptosis-related Changes},
journal = {Journal of Visualized Experiments},
year = {2026},
doi = {10.3791/70711}
}
EUVIMED